TRIM28 and cancer: In summary, our findings in this study elucidated the close connections between TRIM28 expression and immune cell infiltration, immune responses, immunotherapy resistance, the TMB, MSI, and neoantigens in a variety of human cancers, indicating that TRIM28 is a potentially valuable immune response indicator and a molecular biomarker for predicting the prognosis of cancer patients.